Dental and periodontal history of oncologic patients on parenteral bisphosphonates with or without osteonecrosis of the jaws: A pilot study

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 106, Issue 6, 2008, Pages

  Carmagnola, Daniela ^a   Celestino, Silvio ^a   Abati, Silvio ^a  

^a Dental Clinic   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; IMIDAZOLE DERIVATIVE; ZOLEDRONIC ACID;

AGED; ARTICLE; BONE NECROSIS; CHEMICALLY INDUCED DISORDER; FEMALE; HEALTH SURVEY; HUMAN; JAW DISEASE; MALE; MIDDLE AGED; NEOPLASM; OSTEOLYSIS; PATHOLOGY; PERIODONTICS; PILOT STUDY; RETROSPECTIVE STUDY; RISK FACTOR; STOMATITIS; TOOTH EXTRACTION;

AGED; AGED, 80 AND OVER; ALVEOLAR BONE LOSS; ANTINEOPLASTIC AGENTS; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; DMF INDEX; FEMALE; HUMANS; IMIDAZOLES; JAW DISEASES; MALE; MIDDLE AGED; NEOPLASMS; OSTEONECROSIS; PERIODONTAL INDEX; PILOT PROJECTS; RETROSPECTIVE STUDIES; RISK FACTORS; STOMATITIS, DENTURE; TOOTH EXTRACTION;

EID: 55549121545     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2008.07.011     Document Type: Article

References (25)

1. Migliorati C.A., Casiglia J., Epstein J., Jacobsen P.I., Siegel M.A., and Woo S.-B. Managing the care of patients with bisphosphonate-associated osteonecrosis. An American Academy of Oral Medicine position paper. J Am Dent Assoc 136 12 (2005) 1658-1668
2. Gutta R., and Louis P.J. Bisphosphonates and osteonecrosis of the jaws: science and rationale. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104 2 (2007) 186-193
3. Hewitt C., and Farah C.S. Bisphosphonate-related osteonecrosis of the jaws: a comprehensive review. J Oral Pathol Med 36 (2007) 319-328
4. Pazianas M., Miller P., Blumentals W.A., Bernal M., and Kothawala P. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Clin Ther 29 (2007) 1548-1558
5. Migliorati C.A., Siegel M.A., and Elting L.S. Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment. Lancet Oncol 7 (2006) 508-514
6. Nase J.B., and Suzuki J.B. Osteonecrosis of the jaw and oral bisphosphonate treatment. J Am Dent Assoc 137 8 (2006) 1115-1119
7. Woo S.-B., Hellstein J.W., and Kalmar J.R. Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144 (2006) 753-761
8. Bamias A., Kastritis E., Bamia C., Moulopoulos L.A., Melakopoulos I., Bozas G., et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 23 (2005) 8580-8587
9. Lin J.H., Russell G., and Gertz B. Pharmacokinetics of alendronate: an overview. Int J Clin Pract Suppl 101 1 (1999) 18-26
10. Lam D.K., Sándor G.K.B., Holmes H.I., Evans A.W., and Clokie C.M.L. A review of bisphosphonate-associated osteonecrosis of the jaws and its management. JCDA. www.cda-adc.ca/jcda/vol-73/issue-5/417.html Accessed Jan. 9, 2008
11. American Association of Oral and Maxillofacial Surgeons. Position paper on bisphosphonate-related osteonecrosis of the jaws (2006). www.aaoms.org/docs/position_papers/osteonecrosis.pdf Accessed
12. Ponte Fernandez N., Estefania Fresco R., and Aguirre Urizar J.M. Bisphosphonates and oral pathology I. General and preventive aspects. Med Oral Patol Oral Cir Bucal 1-11 5 (2006) 396-400
13. Marx R.E., Sawatari Y., Fortin M., and Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63 (2005) 1567-1575
14. Ruggiero S.L., Mehrotra B., Rosenberg T.J., and Engroff S.L. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62 5 (2004) 527-534
15. Dimitrakopoulos I., Magopoulos C., and Karakasis K. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases. Int J Oral Maxillofac Surg 35 (2006) 588-593
16. World Health Organization Global InfoBase. Dental caries prevalence and serverity. http://www.who.int/infobase/reportviewer.aspx?rptcode=ALL&surveycode =160022a1&dm=6 Accessed Jan. 9, 2008
17. Hardt C.R.E., Gröndahl K., Lekholm U., and Wennström J.L. Outcome of implant therapy in relation to experienced loss of periodontal bone support. Clin Oral Impl Res 13 (2002) 488-494
18. Badros A., Weikel D., Salama A., Goloubeva O., Schneider A., Rapoport A., et al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 24 (2006) 945-952
19. Migliorati C.A., Schubert M.M., Peterson D.E., and Seneda L.M. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone. an emerging oral complication of supportive cancer therapy. Cancer 104 (2005) 83-93
20. Takeyama S., and Shinoda H. Pharmacological actions and pharmacokinetics of bisphosphonates. Clin Calcium 13 (2003) 115-121
21. Ficarra G., Beninati F., Rubino I., Vannucchi A., Longo G., Tonelli P., et al. Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment. J Clin Periodontol 32 11 (2005) 1123-1128
22. Zavras A.I., and Zhu S. Bisphosphonates are associated with increased risk for jaw surgery in medical claims data: is it osteonecrosis?. J Oral Maxillofac Surg 64 (2006) 917-992
23. Hansen T., Kunkel M., Weber A., and Kirkpatrik C.J. Osteonecrosis of the jaws in patients treated with bisphosphonates-histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med 35 (2006) 155-160
24. Zervas K., Verrou E., Teleioudis Z., Vahtsevanos K., Banti A., Mihou D., et al. Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients. Br J Haematol 134 (2006) 620-623
25. Reid I. Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?. Bone 41 (2007) 318-320